Yamaguchi, Masafumi
Shimamatsu, Shinichiro
Edagawa, Makoto
Hirai, Fumihiko
Toyozawa, Ryo
Nosaki, Kaname
Seto, Takashi
Takenoyama, Mitsuhiro
Ichinose, Yukito
Article History
Received: 19 June 2017
Accepted: 27 November 2017
First Online: 4 January 2019
Compliance with ethical standards
:
: Masafumi Yamaguchi: No conflict of interest. Shinichiro Shimamatsu: No conflict of interest. Makoto Edagawa: No conflict of interest. Fumihiko Hirai: No conflict of interest. Ryo Toyozawa: No conflict of interest. Kaname Nosaki: No conflict of interest. Takashi Seto: Received honoraria (lecture fees) from AstraZeneca, Eli Lilly Japan and Ono Pharmaceutical. Received research grants from Astellas Pharma, AstraZeneca, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly Japan, Merck Serono, Nippon Boehringer Ingelheim, Novartis Pharma and Pfizer Japan. Mitsuhiro Takenoyama: Received research grants from Eli Lilly Japan and Ono Pharmaceutical. Yukito Ichinose: No conflict of interest.